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ORIGINAL ARTICLE 
Relationship of Age, BMI, Serum Calcium and Estradiol with BMD in 
Postmenopausal Osteoporotic Females 
Mukhtiar Baig, Mehreen Lateef, Abid Azhar 
Abstract 
Introduction:  The current study was designed to investigate the relationship of age, body mass index (BMI), serum calcium and estradiol with 
bone mineral density (BMD) in postmenopausal females with and without osteoporosis.  
Subjects & Methods: One hundred females were included in this study and were divided into two groups (fifty in each group): postmenopausal 
females without osteoporosis (age:  54.36 ± 0.51 yrs) and postmenopausal females with osteoporosis (age:  59.92 ± 0.68 yrs). BMD assessment 
was done on calcaneous by peripheral ultrasound bone densitometry and T scores were calculated. Serum estradiol was measured by ELIZA and 
calcium levels were determined by using spectrophotometric kit.  
Results: BMD was significantly lower in postmenopausal osteoporotic females as compared to postmenopausal non-osteoporotic females which 
indicated increased bone loss in osteoporotic group. Serum calcium levels were significantly lower in postmenopausal females with osteoporosis 
(8.73 ± 0.08) as compared to postmenopausal females without osteoporosis (9.04 ± 0.09). BMD was correlated with body weight ( r= 0.50, 
p<0.05; r= 0.45, p<0.05) and BMI (r=0.61, p<0.01; r= 0.31, p<0.05) in both groups. Negative correlation of BMD was found with age (r= -0.67, 
p<0.01r= -0.57, p<0.05) and calcium (r= -0.44, p<0.05; r= -0.38, p<0.05) in postmenopausal females with and without osteoporosis respectively. 
Osteopenia was detected in postmenopausal females without osteoporosis.  
Conclusion: It is concluded that increasing age, low body weight, low BMI, and low BMD are few of the contributing factors to osteoporosis.  
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Introduction 
Osteoporosis is a metabolic bone disorder that affects 
more than 200 million people worldwide1. The 
disease is characterized by low bone mass, which 
makes bones fragile and susceptible to fractures. 
Osteoporotic fractures are more common in the 
elderly and result in excess morbidity and mortality 
in this population2. In 1994, the World Health 
Organization3 (WHO) proposed a clinical definition 
of osteoporosis based on measurements of BMD. 
According to the WHO definition, a patient is 
osteoporotic based on a BMD measurement that is 
2.5 standard deviations (SDs) below typical peak 
bone mass of young healthy white women. This 
measurement of standard deviation from peak mass is 
called the T score. Regarding the interpretation of 
bone densitometric findings, a T-score of more than 1 
standard deviation (SD) but less peak value confirms 
osteopenia and a level more than 2.5 SDs below the 
mean peak value is diagnostic of osteoporosis. 
The risk factors of osteoporosis are modifiable and 
non modifiable. The non modifiable factors are 
advanced age, female gender White/Asian race,  
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low peak bone mass, family history of osteoporosis, 
personal history of fracture, low body mass index and 
modifiable factors are smoking, inadequate calcium 
intake, inadequate vitamin D, low body weight (BMI 
<21 kg/m2), estrogen deficiency, hypogonadism, 
chronic glucocorticoid therapy2. 
The incidence of osteoporotic fractures is increasing 
in Pakistan because of the increasing age of the 
population and many other factors are also implicated 
in this process. Sultan et al4., (2006) found in their 
study that the frequency of osteoporosis was more 
common in poor, illiterate, multiparous, sedentary 
women with imbalanced diet.  
The treatment of established osteoporosis is complex 
and costly and having many long term undesirable 
effects. Therefore, it is essential to find out the risk 
factors for developing osteoporosis, so that 
modifiable factors can be avoided to decrease the 
incidence of osteoporosis.   
The current study was designed to explore the 
relationship of BMD with age, BMI, serum calcium 
and estradiol in postmenopausal females with and 
without osteoporosis.  
 
Subjects & Methods 
 
One hundred (100) female subjects were divided into 
two groups (fifty in each group: postmenopausal 
females without osteoporosis (age: 54.36 ± 0.51) and 
postmenopausal osteoporotic females (age: 59.92 ± 
0.68). Subjects on corticosteroids and on hormone 
replacement therapy were excluded.  
The postmenopausal females having age greater than  
fifty years with LMP > 5 yrs and no endocrinal 
disease were included in this study. For this 
obersavational study,  newly diagnosed and untreated 
postmenopausal osteoporotoic females were selected 
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from different osteoporotic clinics with age limit of 
not less than fifty years. These subjects were free 
from any endocrinal disease. Questionnaires were 
filled in by the subjects, including their case-history, 
fracture history (if any) along with their dietary 
habits and height, weight, waist circumference, hip 
circumference, age at menarche, years since 
menopause, and history of disease were recorded. 
Five mlilliliters of blood was drawn from each 
subject and after centrifugation (3,000 rpm) within an 
hour of blood collection; serum was stored at −70°C 
for subsequent analyses. The samples were analyzed 
for estradiol and calcium. Serum estradiol was 
measured by ELISA kits, supplied by DSL, USA. 
Serum calcium levels were determined by using 
spectrophotometric kit, supplied by International 
Diagnostic Links, USA. Bone mass density 
assessment was done on the calcaneous (heel) by 
peripheral ultrasound bone densitometry by Bone 
Sonometer (IEC 601-1 Class II Type BF.IPXO), and 
T-scores were calculated. Bone mass density was 
measured by quantitative ultrasound (QUS) as it has 
the advantage of being small, portable, relatively 
inexpensive, and using non ionizing radiation5.  
Statistical analyses: The statistical analyses were 
performed using statistical software Statistica 5.0 
(Stat Soft, USA). The significant difference was 




Figure 1 shows comparison of BMD in the two 
groups. BMD was significantly lower in 
postmenopausal females with osteoporosis as 
compared to postmenopausal females without 
osteoporosis (p< 0.05) showing increased bone loss 
in osteoporotic group. 
Table 1 shows the comparison of physical and 
biochemical parameters of postmenopausal females 
with and without osteoporosis. There was a 
significant difference in age (p<0.05) and serum 
calcium levels (p<0.05) in both groups. 
There was a negative correlation between BMD and 
age (r= -0.67, p<0.01r= -0.57, p<0.05) in 
postmenopausal females with and without 
osteoporosis respectively (Table 2). Serum calcium 
was also negatively  correlated with BMD     (r= - 
0.44, p<0.05; r= -0.38, p<0.05) in both groups. BMD 
was correlated with body weight (r= 0.50, p<0.05;           
r= 0.45, p<0.05) and BMI (r=0.61, p<0.01; r= 0.31, 
p<0.05) in postmenopausal females with and without 
osteoporosis respectively. 
   
 
Table1- Physical and Biochemical parameters of 








Age (yrs) 54.36 ± 0.51 59.92 ± 0.68* 
BMI (kg/m2)  25.69 ± 0.85    27.17 ± 0.81  
Estradiol 
(ng/ml) 
08.89 ±  2.61 05.97 ± 1.1 
Calcium (mg/dl)    09.40 ± 0.09  08.73 ± 0.08* 
*p < 0.05 
 
Table 2- Correlation of BMD with Age, 










Age (yrs) r = -0.57,  
p < 0.05 
r = -0.67  
p < 0.01 
Weight 
(kg) 
r = 0.45  
p < 0.05 
r = 0.50  
p < 0.05 
Height 
(m2) 
r = -0.18 r = -0.16 
BMI 
(kg/m2) 
r = 0.31  
p < 0.05 
r = 0.61 
p < 0.01 
Estradiol 
(ng/ml) 
r = 0.17 r = 0.28 
Calcium 
(mg/dl)  
r = -0.38  
(p<0.05) 
r = -0.44  




Present study shows hat the BMD in postmenopausal 
osteoporotic females is significantly decreased as 
compared to postmenopausal females without 
osteoporosis having similar BMI. Even though BMD 
values of non-osteoporotic postmenopausal females 
were higher than the osteoporotic but these females 
were also osteopenic suggesting a need for some 
intervention  to prevent osteoporosis in such females. 
It has previously been reported that in Faisalabad  
20% postmenopausal women were osteoporotic out 
of 300 postmenopausal women, while 44% were 
suffering from osteopenia, and 36% had normal 
BMD6. Sharma et al7., (2006) found that a substantial 
female population had esteopenia and osteoporosis 
after the age of 45 years. The osteopenia (36.79%) 
with maximum number of both osteoporosis and  
osteopenic women recorded in the age group of (55-
64 years).   
Hafeez et al8, (2009) observed that the risk factors  
in postmenopausal group were low BMD, low 
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oestrogen levels, poor intake of milk and calcium and 
lack of physical exercise. Therefore, it is 
recommended that diet should be balanced with 
proper calcium intake and daily exercise should be 
required to maintain BMD, while postmenopausal 
females require greater calcium intake to avoid 
osteoporosis. 
There was a negative correlation found between 
serum calcium levels and BMD in postmenopausal 
females with and without osteoporosis. It seems that 
to maintain normal calcium levels in blood, bone 
resorption increases as indicated by decreased BMD. 
A deficiency of calcium intake itself is considered a 
major risk factor for osteoporosis9. Low calcium 
intake causes secondary hyperparathyroidism as the 
calcium homeostasis in blood must be kept stable. 
This causes resorption of calcium from the bone with 
ensuing bone loss and an increased susceptibility to 
fractures10-11. 
The importance of calcium in developing and 
maintaining bone mass varies throughout a person’s 
life. At times of rapid and significant bone growth 
(during the teenage years) or rapid bone loss (after 
age 50 years), calcium is more important. Therefore, 
to reduce the risk of osteoporosis, calcium intake 
should be the highest during adolescence and after 
age 50 years12. It is suggested that postmenopausal 
women require greater calcium intake to maintain 
calcium balance. 
Serum calcium level was significantly higher in 
postmenopausal females without osteoporosis as 
compared to postmenopausal females with 
osteoporotic. This was similar to reported higher 
calcium levels in other study13.  
Present study found that BMD is positively correlated 





















increase weight there would be increased peak bone 
mass which is protective of osteoporosis.  These 
results are similar as found by other studies14-17. 
Keramat et al18., (2008) found that weight less than 
60 kg, height less than 155 cm and BMI less than 26 
have been as a risk factor for osteoporosis. Robbins 
et al19., (2006) in their large epidemiological studies 
analysis observed that weight alone is a better 
predictor of BMD than BMI.  
In the present study, BMI was significantly correlated 
with BMD. Several studies reported that obesity 
(greater body weight and BMI) is associated with 
higher BMD14-15. The protective effect of obesity on 
bone loss appears to be related to the both mechanical 
factors and estrogen synthesis in adipose tissues20. 
However, since obesity is an important risk factor for 
cardiovascu- lar disease and diabetes, therefore, 
appropriate body mass index (20-25 kg/m2) or 
prevention for leanness should be recommended for 
good general health15. 
Present study found negative correlation of BMD 
with age. These results are consistent with several 
other studies4,15-16. A study observed that when the 
menstrual cycles get irregular toward menopause, the 
serum calcium level rises rapidly and reaches 
maximum in 2–5 years after menopause, and then 
slight decrease afterwards21-22.  Because of this 
reason there was decrease level of serum calcium in 
those women who have more duration of menopause 
as compared to those who have less duration.                                                                                      
The limitation of this study is that the mean value of 
BMD of non osteoporotic females was more than -
1SD. It may be because of the low sample size and 
the sample for this study were also collected from 
osteoporosis clinics so the female came over there 
having some problems of bone and were referred by  
-3.5 -3 -2.5 -2 -1.5 -1 -0.5 0 







       Figure 1 comparison of BMD in postmenopausal females with and without osteoporosis  
JBUMDC 2011 
 
JBUMDC 2011;1(1):13-17 Page 16 
 
 




Osteoporosis is a preventable problem. Therefore, it 
is recommended, that we should educate the masses 
about the consequences of osteoporosis and its 
preventive measures. Its awareness campaign should 
be started from the media. The primary approach for 
reducing osteoporosis is to reduce bone loss after 
menopause by maximizing calcium intake and 
guiding them to do exercise regularly and there 
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